Takeda’s sales policy ignites controversy

Takeda is pushing up with its sales policy to increase its revenues of Basen tablets and Madipine tablets in Korea, but faces vigorous challenges from domestic wholesalers.

With a thinner wholesaler margin, Takeda Pharma Korea, the Korean unit of a big Japanese firm, has endeavored to expand its presence in drug logistics market by designating its associate wholesalers across the nation.

...